(a)
(b)
(c)
(d)
(e)
(f)
(g)
Figure 6: Relationships among PLA2, DAG, AEA, PEA, and PLC and mastocytosis clinical variants. PLA2 (a), DAG 18:1 20:4 (b), DAG 18:0 20:4 (c), AEA (d), PEA (e), tryptase (f), and PLC (g) were determined in healthy controls and in 15 patients with indolent variants and 8 patients with advanced variants.